EnWave Corporation (NWVCF) Fair Value & Analysis
Industrials · US · Market cap $19.0M
Fair value as of: Jun 26, 2026
Analysis
EnWave Corporation (NWVCF) currently trades at $0.1600, while our model-based Fair Value estimate is $0.0500 — implying the stock looks roughly 68.8% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
EnWave Corporation designs, constructs, markets, and sells vacuum-microwave dehydration machinery for the food, cannabis, and biomaterial industries in Canada, the United States, and internationally. The company licenses radiant energy vacuum (REV) technology that applies microwave energy under vacuum for drying food products, cannabis, biomaterials, and pharmaceutical products and ingredients. It offers nutraREV for dehydration of fruits, vegetables, herbs, dairy products, meats, and seafood; and quantaREV designed for low-temperature dehydration of solid, semi-solid, granular, or encapsulated food or cannabis products. The company also provides freezeREV for the dehydration of biomaterial and pharmaceutical products; and REVworx, which offers toll manufacturing services for a range of food products. EnWave Corporation is headquartered in Delta, Canada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is EnWave Corporation (NWVCF) undervalued?
What is the fair value of NWVCF?
What is the quality score of NWVCF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.